Company Filing History:
Years Active: 2008
Title: Marie-Claude Denise Michèle Zelveyan: Innovator in Cancer Treatment
Introduction
Marie-Claude Denise Michèle Zelveyan is a distinguished inventor and legal representative based in Asnieres, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pyranone derivatives. His work exemplifies the intersection of legal expertise and scientific innovation.
Latest Patents
Zelveyan holds a patent for pyranone derivatives useful for treating cancer. The invention relates to pyranone derivatives of general formula (I), wherein X is chlorine, bromine, or iodine, and R and R' are independently a hydrogen atom, an alkyl, cycloalkyl, or alkylene group containing 1-20 carbon atoms. These groups may be optionally substituted by a hydroxyl, amino, ether, or halogen group. Additionally, R and R' can form a cycle of 5, 6, 7, or 8 members, which is also optionally substituted. The patent includes a method for preparing these derivatives and their therapeutic use, particularly in treating cancer.
Career Highlights
Zelveyan is affiliated with the Centre National De La Recherche Scientifique, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on cancer therapies, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Zelveyan collaborates with notable colleagues, including Joanna Bakala and Denyse Herlem, who contribute to his research endeavors. Their combined expertise enhances the development of effective treatments and fosters a collaborative environment for scientific discovery.
Conclusion
Marie-Claude Denise Michèle Zelveyan stands out as a key figure in the fight against cancer through his innovative work on pyranone derivatives. His contributions not only reflect his scientific acumen but also his dedication to improving healthcare outcomes.